These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7519223)

  • 1. Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid.
    Borges E; Wiesmüller KH; Jung G; Walden P
    J Immunol Methods; 1994 Aug; 173(2):253-63. PubMed ID: 7519223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines.
    Shirai M; Chen M; Arichi T; Masaki T; Nishioka M; Newman M; Nakazawa T; Feinstone SM; Berzofsky JA
    J Infect Dis; 1996 Jan; 173(1):24-31. PubMed ID: 8537666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
    BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
    Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses.
    Oseroff C; Sette A; Wentworth P; Celis E; Maewal A; Dahlberg C; Fikes J; Kubo RT; Chesnut RW; Grey HM; Alexander J
    Vaccine; 1998 May; 16(8):823-33. PubMed ID: 9627940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides.
    Widmann C; Romero P; Maryanski JL; Corradin G; Valmori D
    J Immunol Methods; 1992 Oct; 155(1):95-9. PubMed ID: 1383348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells.
    Miller SD; Butler LD; Cleveland RP; Moorhead JW; Claman HN; Chiller JC
    Cell Immunol; 1983 Dec; 82(2):378-93. PubMed ID: 6197193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcutaneous immunization in mice: induction of T-helper and cytotoxic T lymphocyte responses and protection against human papillomavirus-induced tumors.
    Dell K; Koesters R; Gissmann L
    Int J Cancer; 2006 Jan; 118(2):364-72. PubMed ID: 16052529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein.
    Martinon F; Gras-Masse H; Boutillon C; Chirat F; Deprez B; Guillet JG; Gomard E; Tartar A; Levy JP
    J Immunol; 1992 Nov; 149(10):3416-22. PubMed ID: 1385524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immune responses induced by in vivo priming with a lipid-conjugated multimeric antigen peptide.
    Nardelli B; Tam JP
    Immunology; 1993 Jul; 79(3):355-61. PubMed ID: 8104882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipopeptide stimulation of MHC class I-restricted memory cytotoxic T lymphocytes from equine infectious anemia virus-infected horses.
    Ridgely SL; McGuire TC
    Vaccine; 2002 Mar; 20(13-14):1809-19. PubMed ID: 11906769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination.
    Thomson SA; Sherritt MA; Medveczky J; Elliott SL; Moss DJ; Fernando GJ; Brown LE; Suhrbier A
    J Immunol; 1998 Feb; 160(4):1717-23. PubMed ID: 9469429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+ CTL priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivity.
    Bijker MS; van den Eeden SJ; Franken KL; Melief CJ; Offringa R; van der Burg SH
    J Immunol; 2007 Oct; 179(8):5033-40. PubMed ID: 17911588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity.
    Davila E; Celis E
    J Immunol; 2000 Jul; 165(1):539-47. PubMed ID: 10861094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide based cytotoxic T-cell vaccines; delivery of multiple epitopes, help, memory and problems.
    Elliott SL; Pye S; Le T; Mateo L; Cox J; Macdonald L; Scalzo AA; Forbes CA; Suhrbier A
    Vaccine; 1999 Apr; 17(15-16):2009-19. PubMed ID: 10217601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiepitope Trojan antigen peptide vaccines for the induction of antitumor CTL and Th immune responses.
    Lu J; Higashimoto Y; Appella E; Celis E
    J Immunol; 2004 Apr; 172(7):4575-82. PubMed ID: 15034075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of a cytotoxic T cell response by co-injection of a T helper peptide and a cytotoxic T lymphocyte peptide in incomplete Freund's adjuvant (IFA): further enhancement by pre-injection of IFA alone.
    Valmori D; Romero JF; Men Y; Maryanski JL; Romero P; Corradin G
    Eur J Immunol; 1994 Jun; 24(6):1458-62. PubMed ID: 7515816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors.
    Ossendorp F; Mengedé E; Camps M; Filius R; Melief CJ
    J Exp Med; 1998 Mar; 187(5):693-702. PubMed ID: 9480979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of measles virus-specific cytotoxic T-cell responses after intranasal immunization with synthetic peptides.
    Partidos CD; Vohra P; Steward MW
    Immunology; 1996 Feb; 87(2):179-85. PubMed ID: 8698377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy.
    Diehl L; den Boer AT; Schoenberger SP; van der Voort EI; Schumacher TN; Melief CJ; Offringa R; Toes RE
    Nat Med; 1999 Jul; 5(7):774-9. PubMed ID: 10395322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-lasting anti-viral cytotoxic T lymphocytes induced in vivo with chimeric-multirestricted lipopeptides.
    Sauzet JP; Déprez B; Martinon F; Guillet JG; Gras-Masse H; Gomard E
    Vaccine; 1995 Oct; 13(14):1339-45. PubMed ID: 8585291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.